Inventor · disambiguated record
Patrick William Garibay
Also filed as: GARIBAY PATRICK W · GARIBAY PATRICK WILLIAM
36 granted patents·18 pending applications·290 citations·filing 2003–2022
97Inventor score
Files withNOVO NORDISK AS27GARIBAY PATRICK WILLIAM4NOVO NORDISK HEALTHCARE AG4KODRA JANOS TIBOR2MADSEN PETER2
Top patents by PatentIndex Score
54 records- 0194US8648041B2Double-acylated GLP-1 derivativesGARIBAY PATRICK WILLIAM·Filed 2010·Granted Feb 11, 2014·31 cites·30 claims
- 0294US8067362B2Insulin derivativesKODRA JANOS TIBOR·Filed 2006·Granted Nov 29, 2011·27 cites·6 claims
- 0392US9006178B2Double-acylated GLP-1 derivatives with a linkerKOFOED JACOB·Filed 2011·Granted Apr 14, 2015·23 cites·26 claims
- 0492US8691759B2Protease stabilized, acylated insulin analoguesMADSEN PETER·Filed 2009·Granted Apr 8, 2014·15 cites·14 claims
- 0591US10604554B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2018·Granted Mar 31, 2020·3 cites·20 claims
- 0691US10308700B2GLP-1 derivativesNOVO NORDISK AS·Filed 2017·Granted Jun 4, 2019·10 cites·16 claims
- 0791US9067977B2Peptides derivatized with A-B-C-D- and their therapeutical useNOVO NORDISK AS·Filed 2013·Granted Jun 30, 2015·18 cites·22 claims
- 0890US8895694B2Glucagon-Like Peptide-1 derivatives and their pharmaceutical useSPETZLER JANE·Filed 2008·Granted Nov 25, 2014·29 cites·11 claims
- 0989US9045560B2Protease stabilized, acylated insulin analoguesNOVO NORDISK AS·Filed 2013·Granted Jun 2, 2015·12 cites·14 claims
- 1088US9758560B2GLP-1 derivativesLAU JESPER·Filed 2012·Granted Sep 12, 2017·11 cites·3 claims
- 1188US8933021B2Insulin derivativeHUBALEK FRANTISEK·Filed 2007·Granted Jan 13, 2015·8 cites·14 claims
- 1287US10689429B2Double-acylated GLP-1 compoundsNOVO NORDISK AS·Filed 2015·Granted Jun 23, 2020·7 cites·11 claims
- 1387US8815802B2GLP-1 analogues and derivativesKALTHOFF CHRISTOPH·Filed 2010·Granted Aug 26, 2014·19 cites·12 claims
- 1487US8476228B2Insulin derivativesKODRA JANOS TIBOR·Filed 2011·Granted Jul 2, 2013·6 cites·9 claims
- 1586US9708383B2Double-acylated GLP-1 derivativesMADSEN ALICE RAVN·Filed 2011·Granted Jul 18, 2017·14 cites·16 claims
- 1685US10000542B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2013·Granted Jun 19, 2018·6 cites·19 claims
- 1784US9409966B2Glucagon-like peptide-1 derivatives and their pharmaceutical useNOVO NORDISK AS·Filed 2014·Granted Aug 9, 2016·6 cites·22 claims
- 1884US8796205B2Insulin derivativeJONASSEN IB·Filed 2007·Granted Aug 5, 2014·6 cites·11 claims
- 1984US8722620B2Insulin derivativesFYNBO CHARLOTTE HARKJAER·Filed 2007·Granted May 13, 2014·11 cites·29 claims
- 2080US8053410B2Pegylated factor VII glycoformsNOVO NORDISK HEALTH CARE A G·Filed 2009·Granted Nov 8, 2011·4 cites·2 claims
- 2178US8710000B2Insulin derivativeGARIBAY PATRICK WILLIAM·Filed 2008·Granted Apr 29, 2014·2 cites·17 claims
- 2277US10946074B2GLP-1 derivatives and uses thereofNOVO NORDISK AS·Filed 2017·Granted Mar 16, 2021·2 cites·15 claims
- 2377US8865868B2Conjugated proteins with prolonged in vivo efficacyBEHRENS CARSTEN·Filed 2009·Granted Oct 21, 2014·4 cites·9 claims
- 2476US9556250B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2013·Granted Jan 31, 2017·2 cites·15 claims
- 2576US9150633B2Insulin analogues with an acyl and alkylene glycol moietyMADSEN PETER·Filed 2008·Granted Oct 6, 2015·3 cites·4 claims
- 2675US9657079B2Truncated GLP-1 derivatives and their therapeutical useNOVO NORDISK AS·Filed 2014·Granted May 23, 2017·2 cites·14 claims
- 2774US10822385B2EGF(A) analogues with fatty acid substituentsNOVO NORDISK AS·Filed 2017·Granted Nov 3, 2020·1 cites·28 claims
- 2874US9732137B2Semi-recombinant preparation of GLP-1 analoguesLAU JESPER FAERGEMAN·Filed 2008·Granted Aug 15, 2017·4 cites·11 claims
- 2972US10259856B2Protease stabilized acylated insulin analoguesNOVO NORDISK AS·Filed 2015·Granted Apr 16, 2019·1 cites·18 claims
- 3066USRE46170EInsulin derivativesNOVO NORDISK AS·Filed 2014·Granted Oct 4, 2016·0 cites·9 claims
- 3165US9480753B2FGF21 derivatives with albumin binder A-B-C-D-E- and their useTAGMOSE TINA MØLLER·Filed 2010·Granted Nov 1, 2016·2 cites·10 claims
- 3265US2008171695A1Insulin DerivativesNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 3364US2010028939A1Use of Galactose Oxidase for Selective Chemical Conjugation of Protractor Molecules to Proteins of Therapeutic InterestNOVO NORDISK HEALTHCARE AG·Filed 2008·Application pending·0 cites
- 3464US2014274903A1Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interestNOVO NORDISK HEALTHCARE AG·Filed 2014·Application pending·0 cites
- 3563US8859493B2Insulin derivativesGARIBAY PATRICK WILLIAM·Filed 2012·Granted Oct 14, 2014·0 cites·15 claims
- 3663US2019112348A1Protease stabilized, acylated insulin analoguesNOVO NORDISK AS·Filed 2018·Application pending·0 cites
- 3762US11518795B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2019·Granted Dec 6, 2022·0 cites·1 claims
- 3859US2008039373A1Pegylated Factor VII GlycoformsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 3958US2006198819A1Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interestNOVO NORDISK HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 4058US2010292133A1Truncated glp-1 derivaties and their therapeutical useNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 4158US2010261637A1Peptides derivatized with a-b-c-d- and their therapeutical useNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 4257US9655974B2N-terminal modified FGF21 compoundsTAGMOSE TINA MOELLER·Filed 2011·Granted May 23, 2017·1 cites·4 claims
- 4357US2020407409A1Egf(a) analogues with fatty acid substituentsCHEN JIANHE·Filed 2020·Application pending·0 cites
- 4455US2023233650A1Novel fatty acid modified urocortin 2 derivatives and the uses thereofNOVO NORDISK AS·Filed 2022·Application pending·0 cites
- 4554US2010317057A1Semi-recombinant preparation of glp-1 analoguesNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 4649US2022265777A1Solid compositions comprising a glp-1 agonist, an sglt2 inhibitor and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acidNOVO NORDISK AS·Filed 2020·Application pending·0 cites
- 4749US2010227796A1Insulin DerivativesNOVO NORDISK AS·Filed 2010·Application pending·0 cites
- 4849US2005113565A1Pegylated factor VII glycoformsFiled 2003·Application pending·0 cites
- 4948US11274135B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2013·Granted Mar 15, 2022·0 cites·15 claims
- 5047US2015210745A1Double-Acylated GLP-1 Derivatives with a LinkerNOVO NORDISK AS·Filed 2015·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Patrick William Garibay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →